Dan Zandberg
Clinical trials sponsored by Dan Zandberg, explained in plain language.
-
Tailored treatment tested for tough head and neck cancers
Disease control CompletedThis study tested a personalized approach for patients with advanced head and neck cancer that had worsened despite prior immunotherapy. Doctors analyzed each patient's tumor to choose a second immunotherapy drug to add to a standard one, aiming to better control the cancer. The …
Phase: PHASE2 • Sponsor: Dan Zandberg • Aim: Disease control
Last updated Apr 04, 2026 06:34 UTC
-
Cancer trial questions: can patients stop treatment after one year?
Disease control CompletedThis study aimed to find the best length of immunotherapy treatment for people with advanced cancers. It enrolled 161 patients whose cancer had remained stable after one year of treatment. Researchers randomly assigned participants to either stop their immunotherapy or continue i…
Phase: PHASE3 • Sponsor: Dan Zandberg • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC